Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Aug 20, 2020 08:14AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Folks the exact price for the Zenith shares (established in 2013) will only be known when Don puts out an IPO.
EOM ... Koo